Trial intelligence / Profile preview

PERSONAL pilot study of remote precision amlodipine titration for hypertension

2020-002494-10Phase 4Unknown

Sponsor
Queen Mary University of London
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of amlodipine in essential hypertension and hypertension (HTN) (2 arms), sponsored by Queen Mary University of London. Status: unknown.

02

Drugs

amlodipine
03

Conditions

essential hypertensionhypertension (HTN)

Beyond the preview

Go deeper on 2020-002494-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002494-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call